News August 13, 2018 Getting started & OrganoPlate® Protocols – Mimetas We want to offer you the best possible experience when using the OrganoPlate® for your… Super User 0 Love0
News August 13, 2018 Paragon Bioservices Announces Two Key Leadership Promotions – Paragon Bioservices, Inc. Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven… Super User 0 Love0
News August 13, 2018 Senseonics Begins U.S. Commercialization of Eversense Continuous Glucose Monitoring System With First Shipment, First Users and First Policy Coverage | Business Wire Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization… Super User 0 Love0
News August 13, 2018 Johns Hopkins receives $30 million to lead research consortium – Hub Johns Hopkins University has been awarded up to $30 million to lead a consortium of… Super User 0 Love0
News August 13, 2018 Investment Boom in MoCo Venture Capital - Generating Opportunity in Montgomery County (more…) Super User 0 Love0
News August 13, 2018 Rexahn Issues Mid-Year Shareholder Letter to Review Recent Progress and Clinical Plans | Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics… Super User 0 Love0
BHI Weekly News Archives August 7, 2018 315th Edition – August 7, 2018 BioHealth Innovation If you are having trouble viewing this email, please click here August 7,… Super User 0 Love0
News August 6, 2018 Huge Discount for BioHealth Innovation and Partners to Next Month’s RESI Conference, 9/6, Boston Meet RESI’s Network of Global Investors and Channel Partners This fall, the Redefining Early Stage Investments… Super User 0 Love0
News August 6, 2018 Landos Biopharma Initiates Phase 1 Clinical Trial of BT-11, an Oral LANCL2 Agonist for Treatment of | Nutritional Immunology and Molecular Medicine Laboratory Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing improved treatments for autoimmune diseases,… Super User 0 Love0
News August 6, 2018 Funding Opportunity: BARDA DRIVe EZ-BAA As a BARDA DRIVe Accelerator, the Center for Biotechnology is pleased to announce that the… Super User 0 Love0